Nurses Lead Toxicity Monitoring in Indolent Lymphoma Care
At SOHO 2025, Lorenzo Falchi, MD, highlighted the critical role of nurses in monitoring and educating patients on toxicities from novel lymphoma therapies.
Precision Supportive Care Centers Patient Preference in Oncology
Michelle Kirschner, MSN, RN, ACNP, APRN-BC, discusses how precision supportive care tailors interventions to patient needs.
Safety Management With Amivantamab Plus Lazertinib in NSCLC
Benjamin Besse, MD, PhD, shares AE management strategies with amivantamab/lazertinib in EGFR-positive NSCLC following CHRYSALIS-2 results.
Rx Road Map: Durvalumab for Endometrial Cancer
Read an advanced practice nurse's tips for treating patients with endometrial cancer with durvalumab.
Adverse Events of Menin Inhibitors in AML: What Nurses Should Know
Ghayas C. Issa, MD, MS, discusses key adverse events of menin inhibitors in NPM1-mutated and KMT2Ar AML.
Proactive Nursing Care for PI3K and AKT Inhibitor Adverse Effects
Expert Kelsey Martin shares nursing insights on balancing glucose control and GI side effects when caring for patients on PI3K and AKT inhibitors.
Structure to Safety: A Nurse's Guide to Safe ADC Care
Familiarity with each component of antibody-drug conjugates helps nurses and APPs deliver proactive adverse event management to patients with cancer.
Monitoring Severe Adverse Effects of Bispecifics in Multiple Myeloma
Lisa Hwa Christenson, DNP, CNP, FAPO, shares best practices for monitoring CRS and ICANS with BCMA bispecific antibodies in community oncology.
Opinion: Nursing Considerations for Emerging CLDN6-Targeted Therapies
Understanding which patients may benefit from CLDN6-targeting immunotherapy and recognizing potential adverse effects is essential for oncology nurses.
Nurses, APPs Critical to Getting Oncology Patients Newer Therapies
The role of nurses and APPs is crucial to ensuring patients with cancer can receive newer therapies, shares David A. Braun, MD, PhD.
Patient Views on Skin-Related AEs May Affect Cancer Treatment Choices
Survey results show patients may overestimate dermatologic AEs from anti-cancer therapies, raising concerns for treatment adherence.
Managing Infection Risk With Bispecific Antibodies in Myeloma
Nurse practitioner Beth Faiman shares strategies to reduce infection risk in patients receiving bispecific antibodies for multiple myeloma.
Nurses Are Key to Reducing Opioid Use After Colorectal Surgery
Ronald Bleday, MD, discusses how nurses support a step-wise model to minimize opioid use after colorectal surgery while ensuring safe pain control.
Precision Supportive Care Individualizes Patient Experience
Catering supportive care to the individual being treated helps better meet the needs of each patient, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.
Managing CRS in Hematologic Cancers: A Nursing Perspective
CRS is a common but manageable toxicity of CAR T-cell therapy and bispecific antibodies. Learn strategies to identify and manage this adverse effect.
Safer Care in Breast Cancer: Expert Advice for Managing ADC Toxicities
Paolo Tarantino, MD, PhD, discusses ADC structure, toxicity, and nursing consideration for the treatment of patients with breast cancer.
How Nurses Can Assess and Manage Talquetamab Toxicities
Nurse practitioner Beth Faiman outlines nursing strategies to monitor, assess, and manage toxicities associated with talquetamab in multiple myeloma.
Opioid Reduction in Surgical Oncology Supported by Cultural Shift
A significant reduction of opioid use in patients after colorectal surgery was supported by clinician and patient compliance, says Ronald Bleday, MD.
How Can Nurses Provide Better Symptom Management for Patients With MPNs?
A nurse-led clinic to aid in patient-reported symptom burden had high patient satisfaction.
What Toxicities Are Common for ADCs Approved in Breast Cancer?
Melissa Rikal, MSN, FNP-BC, AOCNP, explained that adverse effects are common among the available antibody-drug conjugates in breast cancer.
Personalizing CDK4/6 Inhibitor Care to Reduce Adverse Events
Oncology nurses play a key role in monitoring, managing, and personalizing CDK4/6 inhibitor treatment to minimize toxicities and protect quality of life, according to Courtney Moore, APRN, FNP-C, OCN.
What Are the Barriers to CAR T-Cell Therapy Access in Multiple Myeloma?
Treatment access can still affect patients in urban communities, said Mary Steinbach, DNP, APRN.
Opinion: ADC Offers Hope for Patients with Rare Leukemia
APRN-Led Model Feasible in Post-Trial Care Transition
A care model led by advanced practice nurses was feasible in providing supportive care and linking providers through post-trial care transitions.
Adult/Pediatric Team Collaborations Improve Transitions to AYA Cancer Care
Maria C. Velez, MD, shared that teamwork between pediatric and adult care teams can make the transition of care smoother for AYA patients.
Helping Patients Weigh Extended Endocrine Therapy With the BCI
Michelle Kirschner, MSN, RN, ACNP, APRN-BC, explains how educating patients about the Breast Cancer Index can support informed endocrine therapy decisions.
Diet, Exercise Help Patients “Flourish” In Cancer Survivorship
Survivorship expert Michelle Kirschner, MSN, RN, ACNP, APRN-BC, says that “doable changes” can enhance the lives of patients surviving cancer.
Supporting Mental Health and Autonomy for Older Adults With Cancer
Explore essential mental health support strategies for older adults with cancer, addressing grief, community resources, and tailored care approaches.
Opinion: IV Magnesium May Help Prevent Cisplatin-Induced AKI
Oncology nurses can assess patients’ risk factors and advocate for preventive strategies that protect kidney function during cisplatin therapy.
Complementary Supportive Care Can Go Far for Patients With Cancer
Getting to the root of patients’ issues can provide support for their cancer journey through accessible means, says Heather Jackson, PhD, APRN, FNP-BC, NEA-BC, FAA-NP.
Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC
Lutetium Lu 177 Dotatate Brings Partial Response in Metastatic BP-NETs